AGN : Analysis & Opinions

  1. Retail Investors May Face Capital Gains Tax on Pfizer Allergan ...

    November 30, 2015
    The Pfizer-Allergan merger may end up costing retail investors a pretty penny, but they may be able to minimize their losses. ...
  2. Why Are Pfizer And Allergan Talking About A Split Even Before ...

    November 24, 2015
    The proposed merger between Pfizer and Allergan might be headed towards a split in the future. Why?
  3. Positive GDP Number Increases Chance of Rate Hike

    November 24, 2015
    The chances for a December hike in interest rates became stronger this morning with an uptick in U.S. GDP numbers during ...
  4. Pfizer-Allergan Merger Makes Biggest Firm by Sales

    November 23, 2015
    On November 22, 2015, America’s Pfizer and Ireland’s Allergan received their board of directors’ approval to merge in what ...
  5. New Treasury Rules Won't Stop Corporate Inversions

    November 20, 2015
    The US Treasury Department unveiled new rules to curb corporate inversions. But, they may not be enough.
  6. Pfizer and Allergan Talk Mammoth Healthcare Deal

    November 19, 2015
    Pharmaceutical giant Pfizer Inc. is in talks with Botox maker Allergan Plc, to buy the latter in a deal worth $150 billion.
  7. Defensive Investing: Learn from a Hedge Fund Pro

    November 12, 2015
    Looking for ideas on companies, sectors or investments to short? Consider the opinion of this hedge fund luminary.
  8. Pfizer - Allergan: Will This Deal Happen?

    October 30, 2015
    The question for investors is: Will this deal happen?
  9. Target Fires First Shot in Holiday Wars at Wal-Mart

    October 30, 2015
    In a move that has threatened retail giant WalMart (WMT), Target (TGT) has announced that it will offer free shipping and ...
  10. Teva Pharma to Acquire Allergan: Analysts Weigh In

    July 28, 2015
    Teva Pharmaceutical announced a definitive agreement to buy Allergan Inc. for $40.5 billion. What analysts are saying?
  11. Will These High-Flying Stocks Stay Hot in 2015?

    May 22, 2015
    These 10 stocks were on fire in 2014. Will they stay hot?
  12. The Best Way Into Big Pharma? See This ETF (IHE)

    November 21, 2014
    Pharma investing isn't for everyone, but sector-specific ETFs, such as the iShares Dow Jones U.S. Pharmaceuticals ETF (IHE), ...
  13. All Quiet On The Market Front: Dow, S&P 500, Nasdaq Virtually ...

    November 12, 2014
  14. Technical Outlook For Four Exceptionally Hot Stocks

    January 15, 2014
    These four large cap stocks are all up more than 30% in the last three months. Here's the technical outlook going forward.
  15. Yet Another Failure Has Rigel Pharmaceuticals Almost Back To ...

    August 26, 2013
    Rigel sees yet another clinical failure from its pipeline.
  16. After A Sharp Pullback, Is Allergan Pretty Enough?

    July 31, 2013
    Down on fears about generics and the pipeline, the Street may be underestimating Allergan
  17. Valeant Eyes Bausch & Lomb

    May 28, 2013
    Canadian pharmaceutical company Valeant has made a name for itself through acquisitions. On May 27 it announced that it was ...
  18. Allergan Third Quarter Earnings

    October 30, 2012
    Allergan (NYSE:AGN) announced its results for the most recent quarter on October 30, 2012. Allergan is a global specialty ...
  19. Valeant Works Its Mojo With Medicis

    September 7, 2012
    Valeant makes a bold but logical bid for Medicis.
  20. Allergan and Other NYSE Stocks Making Big Moves

    August 1, 2012
    After this morning's trading, the market is looking good. The Nasdaq has increased 0.1%; the S&P 500 is trading up 0.5%; ...
  21. Obagi Puts Its Problems Behind It

    May 25, 2012
    A year ago, Obagi Medical Products faced some problems in Texas that presented an investment opportunity. One year later ...
  22. 6 Overbought Stocks To Watch

    March 30, 2012
    Let's take a look at a few stocks that have recently entered overbought territory because these could be candidates for a ...
  23. Top Drug Stocks

    June 30, 2011
    Recently, three strong factors are driving investors to the drug sector.
  24. Obagi's Pitfalls Provide Investment Opportunity

    May 24, 2011
    Obagi's stock dropped 24% after announcing a 13-cent loss in its first quarter. Find out why this presents an opportunity ...
  25. Novartis Brings Alcon Into The Fold

    December 16, 2010
    Novartis closes the deal for Alcon.
  26. Allergan Winning Wall Street's Beauty Pageant

    November 3, 2010
    Allergan's earnings aren't special, but the stock is basking in Wall Street's love. Is it simply a case of lipstick on a ...
  27. Novartis Looks For 20/20 Vision With Alcon

    January 11, 2010
    The Swiss drug maker hopes to take full ownership of Alcon later in the year. Find out what it'll mean for these two companies.
Trading Center